These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 28099741)
1. Abortion choices among women in Cambodia after introduction of a socially marketed medicated abortion product. Sotheary K; Long D; Mundy G; Madan Y; Blumenthal PD Int J Gynaecol Obstet; 2017 Feb; 136(2):205-209. PubMed ID: 28099741 [TBL] [Abstract][Full Text] [Related]
2. Towards safe abortion access: an exploratory study of medical abortion in Cambodia. Petitet PH; Ith L; Cockroft M; Delvaux T Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068 [TBL] [Abstract][Full Text] [Related]
3. Provision of harm-reduction services to limit unsafe abortion in Tanzania. Kahabuka C; Pembe A; Meglioli A Int J Gynaecol Obstet; 2017 Feb; 136(2):210-214. PubMed ID: 28099731 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of early induced medical abortion with mifepristone when beginning progestin-only contraception on the same day. Douthwaite M; Candelas JA; Reichwein B; Eckhardt C; Ngo TD; Domínguez A Int J Gynaecol Obstet; 2016 Jun; 133(3):329-33. PubMed ID: 26969144 [TBL] [Abstract][Full Text] [Related]
5. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives. Tamang A; Tamang J Reprod Health Matters; 2005 Nov; 13(26):110-9. PubMed ID: 16291492 [TBL] [Abstract][Full Text] [Related]
6. Choosing early pregnancy termination methods in Urban Mozambique. Mitchell EM; Kwizera A; Usta M; Gebreselassie H Soc Sci Med; 2010 Jul; 71(1):62-70. PubMed ID: 20452107 [TBL] [Abstract][Full Text] [Related]
7. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Jensen JT; Harvey SM; Beckman LJ Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441 [TBL] [Abstract][Full Text] [Related]
8. Unsafe abortion as a birth control method: maternal mortality risks among unmarried cambodian migrant women on the Thai-Cambodia border. Hegde S; Hoban E; Nevill A Asia Pac J Public Health; 2012 Nov; 24(6):989-1001. PubMed ID: 21551135 [TBL] [Abstract][Full Text] [Related]
9. Instituting medical abortion services: changes in outcome and acceptability related to provider experience. Borgatta L; Burnhill M; Haskell S; Nichols M; Leonhardt K J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):173-6. PubMed ID: 10846332 [TBL] [Abstract][Full Text] [Related]
10. Complications of first-trimester abortion by vacuum aspiration after cervical preparation with and without misoprostol: a multicentre randomised trial. Meirik O; My Huong NT; Piaggio G; Bergel E; von Hertzen H; Lancet; 2012 May; 379(9828):1817-24. PubMed ID: 22405255 [TBL] [Abstract][Full Text] [Related]
11. Availability and prescription of misoprostol for medical abortion in community pharmacies and associated factors in Accra, Ghana. Ganle JK; Busia NT; Maya E Int J Gynaecol Obstet; 2019 Feb; 144(2):167-173. PubMed ID: 30451283 [TBL] [Abstract][Full Text] [Related]
12. Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India. Ganatra B; Manning V; Pallipamulla SP Reprod Health Matters; 2005 Nov; 13(26):65-74. PubMed ID: 16291487 [TBL] [Abstract][Full Text] [Related]
13. Medical abortion and manual vacuum aspiration for legal abortion protect women's health and reduce costs to the health system: findings from Colombia. Rodriguez MI; Mendoza WS; Guerra-Palacio C; Guzman NA; Tolosa JE Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):125-33. PubMed ID: 25702076 [TBL] [Abstract][Full Text] [Related]
14. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion. Briozzo L; Vidiella G; Rodríguez F; Gorgoroso M; Faúndes A; Pons JE Int J Gynaecol Obstet; 2006 Nov; 95(2):221-6. PubMed ID: 17010348 [TBL] [Abstract][Full Text] [Related]
15. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days. Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871 [TBL] [Abstract][Full Text] [Related]
16. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria. Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City. Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534 [TBL] [Abstract][Full Text] [Related]
18. Replacement of dilation and curettage/evacuation by manual vacuum aspiration and medical abortion, and the introduction of postabortion contraception in Pakistan. Zaidi S; Yasmin H; Hassan L; Khakwani M; Sami S; Abbas T Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S40-4. PubMed ID: 24743026 [TBL] [Abstract][Full Text] [Related]
19. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City. Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071 [TBL] [Abstract][Full Text] [Related]
20. Cervical priming with misoprostol before manual vacuum aspiration versus electric vacuum aspiration for first-trimester surgical abortion. Mittal S; Sehgal R; Aggarwal S; Aruna J; Bahadur A; Kumar G Int J Gynaecol Obstet; 2011 Jan; 112(1):34-9. PubMed ID: 21112054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]